Dennis Hom
Keine laufenden Positionen mehr
Vermögen: - $ am 31.05.2024
Karriereverlauf von Dennis Hom
Ehemalige bekannte Positionen von Dennis Hom
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SAGIMET BIOSCIENCES INC. | Finanzdirektor/CFO | 01.10.2017 | 01.08.2023 |
| ACHAOGEN | Finanzdirektor/CFO | 01.01.2013 | 31.03.2014 |
| Investor Relations Kontakt | 01.01.2013 | 31.03.2014 | |
| Public Communications Contact | 01.01.2013 | 31.03.2014 | |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2011 | 01.01.2012 |
Ausbildung von Dennis Hom
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director of Finance/CFO | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sektoral
| Health Technology | 4 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Dennis Hom
- Erfahrung